APA (7th ed.) Citation

ML, R., A, S., GR, W., MA, V., JR, E., C, A., . . . DD, V. H. (1998). Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology, 9(7), 733. https://doi.org/10.1023/a:1008286908930

Chicago Style (17th ed.) Citation

ML, Rothenberg, et al. "Phase I Trial of Paclitaxel and Gemcitabine Administered Every Two Weeks in Patients with Refractory Solid Tumors." Annals of Oncology : Official Journal of the European Society for Medical Oncology 9, no. 7 (1998): 733. https://doi.org/10.1023/a:1008286908930.

MLA (9th ed.) Citation

ML, Rothenberg, et al. "Phase I Trial of Paclitaxel and Gemcitabine Administered Every Two Weeks in Patients with Refractory Solid Tumors." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 9, no. 7, 1998, p. 733, https://doi.org/10.1023/a:1008286908930.